Coronary Stents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Coronary Stents Market

The global coronary stents market is poised for substantial growth, driven by the rising incidence of cardiovascular diseases (CVDs), advancements in medical technology, and expanding access to healthcare services. According to a comprehensive report by Fortune Business Insights, the market was valued at USD 6.68 billion in 2024 and is expected to reach USD 10.66 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.2% during the forecast period.

What Are Coronary Stents?

Coronary stents are small mesh-like tubes inserted into narrowed or blocked coronary arteries during angioplasty procedures. Their primary function is to keep the artery open, ensuring adequate blood flow to the heart. Over the years, innovations in stent technology have significantly enhanced patient outcomes, reduced complications, and minimized repeat procedures.

Technological Advancements Fueling Growth

One of the most significant factors contributing to the market's expansion is technological innovation. Modern coronary stents, particularly drug-eluting stents (DES), have revolutionized interventional cardiology by reducing the chances of restenosis—re-narrowing of the artery. These stents are coated with medication that helps prevent the growth of scar tissue, significantly improving long-term outcomes.

Furthermore, the development of bioresorbable stents—designed to gradually dissolve within the body after fulfilling their purpose—has garnered interest from both clinicians and patients. These devices reduce long-term complications associated with permanent implants, such as inflammation and blood clots.

Increasing Prevalence of Cardiovascular Diseases

Globally, cardiovascular diseases remain the leading cause of death, responsible for an estimated 17.9 million deaths annually. The increasing prevalence of sedentary lifestyles, unhealthy diets, smoking, and stress has further contributed to the rise in heart-related conditions. The growing burden of these diseases is directly driving the demand for effective and minimally invasive treatment options like coronary stenting.

Aging Population Boosting Demand

The aging population is another significant contributor to market growth. Older adults are more susceptible to coronary artery disease (CAD) due to age-related vascular changes and accumulated risk factors over time. With the global population aged 60 years and above expected to double by 2050, the demand for coronary stent procedures is likely to rise accordingly.

Market Segmentation Highlights

The coronary stents market is segmented based on stent type, deployment technique, end-user, and region.

Stent Type: Drug-eluting stents dominate the market, accounting for the largest share due to their effectiveness in reducing complications post-surgery. Bioresorbable stents, though still emerging, show promising growth potential.

Deployment Technique: Balloon-expandable stents are widely adopted for their precision, while self-expanding stents are used in tortuous vessels or cases requiring flexibility.

End Users: Hospitals and ambulatory surgical centers represent the largest user base, driven by rising angioplasty procedures and access to specialized care.

Regional Insights

North America leads the coronary stents market, supported by a well-established healthcare infrastructure, high healthcare spending, and significant awareness of cardiovascular conditions. Europe follows closely, while Asia-Pacific is anticipated to witness the fastest growth rate during the forecast period. In emerging economies like India and China, improving healthcare infrastructure, increasing insurance coverage, and growing awareness are key growth drivers.

Competitive Landscape

Key players in the coronary stents market include:

Abbott Laboratories

Boston Scientific Corporation

Medtronic

Terumo Corporation

B. Braun Melsungen AG

Biotronik SE & Co. KG

MicroPort Scientific Corporation

These companies are heavily investing in research and development, strategic partnerships, and geographic expansion to strengthen their market presence and meet evolving patient needs.

Conclusion

With the combination of technological innovation, rising cardiovascular health concerns, and expanding access to healthcare services, the coronary stents market is expected to maintain a strong growth trajectory. As demand surges and research continues to advance, coronary stents will play an increasingly crucial role in managing cardiovascular diseases worldwide.

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2024

Forecast Period 2025-2032

Historical Period 2019-2023

Growth Rate CAGR of 6.2% from 2025-2032

Unit Value (USD Billion)

Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region

By Stent Type Drug Eluting Stent

Covered Stent

Bare Metal Stent

Bioresorbable Stent

Others (Dual Therapy Stents)

By Material Type Metal

Polymer

By Deployment Self-expandable

Balloon-expandable

By Application Acute Coronary Syndrome (ACS)

Chronic Coronary Syndrome (CCS)

By End-user Hospitals & ASCs

Specialty Clinics

Others

By Region North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)

U.S.

Canada

Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)

Germany

U.K.

France

Italy

Spain

Scandinavia

Rest of Europe

Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)

China

Japan

India

Australia

Southeast Asia

Rest of Asia Pacific

Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)

Brazil

Mexico

Rest of Latin America

Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)

GCC

South Africa

Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.